0.00Open0.60Pre Close0 Volume4 Open Interest62.00Strike Price0.00Turnover7451.16%IV22.67%PremiumDec 27, 2024Expiry Date0.00Intrinsic Value100Multiplier-5DDays to Expiry0.60Extrinsic Value100Contract SizeAmericanOptions Type-0.0780Delta0.0093Gamma132.33Leverage Ratio-445.3659Theta0.0000Rho-10.32Eff Leverage0.0003Vega
DexCom Stock Discussion
Revenue came in at $994.2 million, topping the forecast of $990.71 million and showing growth from last year's $975 million.
The company announced that Teri Lawver, EVP and Chief Commercial Officer, will retire by year-end, with CEO Kevin Sayer temporarily leading the commercial team.
DexCom reaffirmed its 2024 sales outl...
No comment yet